Liver cancer combo therapy shows promise in phase 3 trial
NCT ID NCT02435953
First seen Jan 07, 2026 · Last updated May 13, 2026 · Updated 22 times
Summary
This study tested whether combining two procedures—TACE (a chemo-blocking treatment) and RFA (a heat-based ablation)—works better than TACE alone for people with intermediate-stage liver cancer. 241 participants were randomly assigned to one of the two groups. The main goal was to see if the combination slowed cancer growth longer. Results can help doctors choose the best treatment for this stage of liver cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Minimally Invasive Interventional Division, Medical Imaging Center, Sun Yat-sen University Cancer Center,
Guangzhou, Guangdong, 500060, China
Conditions
Explore the condition pages connected to this study.